While the risk-conferring effect of APOE4 carriage towards major neurocognitive disorders such as AD, Dementia with Lewy Bodies and Parkinson’s Disease Dementia, is well-established [16], the exact role of APOE2 carriage in neurodegeneration is less clear. This evidence concerns the gene APOE and Lewy body dementia.